Lates News

On August 4th, German biotechnology company BioNTech announced its financial report, showing that second quarter revenue more than doubled to 2.6 billion euros (approximately 3 billion US dollars), thanks to the increase in revenue from the COVID-19 vaccine. The company's quarterly net loss was 387 million euros, a significant narrowing from the 800 million euros net loss in the same period last year.